ABSTRACT
Contemporary science has become increasingly multi-disciplinary and team-based, resulting in unprecedented growth in biomedical innovation and technology over the last several decades. Collaborative research efforts have enabled investigators to respond to the demands of an increasingly complex 21st century landscape, including pressing scientific challenges such as the COVID-19 pandemic. A major contributing factor to the success of team science is the mobilization of core facilities and shared research resources (SRRs), the scientific instrumentation and expertise that exist within research organizations that enable widespread access to advanced technologies for trainees, faculty, and staff. For over 40 years, SRRs have played a key role in accelerating biomedical research discoveries, yet a national strategy that addresses how to leverage these resources to enhance team science and achieve shared scientific goals is noticeably absent. We believe a national strategy for biomedical SRRs-led by the National Institutes of Health-is crucial to advance key national initiatives, enable long-term research efficiency, and provide a solid foundation for the next generation of scientists.
Subject(s)
Biomedical Research/organization & administration , COVID-19 , Intersectoral Collaboration , National Institutes of Health (U.S.)/organization & administration , Pandemics , SARS-CoV-2 , Academies and Institutes/organization & administration , Career Mobility , Congresses as Topic , Humans , Policy , Program Evaluation , Research Support as Topic , Societies, Scientific/organization & administration , Stakeholder Participation , United States , Universities/organization & administrationSubject(s)
Congresses as Topic/economics , Congresses as Topic/organization & administration , Coronavirus Infections/economics , Pandemics/economics , Pneumonia, Viral/economics , Research Support as Topic , Societies, Scientific/economics , Societies, Scientific/organization & administration , COVID-19 , Coronavirus Infections/epidemiology , Engineering , Europe , Federal Government , Internationality , Internet , Neurosciences , Pneumonia, Viral/epidemiology , United States , Videoconferencing/economics , Videoconferencing/trendsABSTRACT
The Society for Craniofacial Genetics and Developmental Biology (SCGDB) held its 43rd annual meeting in a virtual format on October 19-20, 2020. The SCGDB meeting included the presentation of the SCGDB Distinguished Scientists in Craniofacial Research Awards to Marilyn Jones and Kerstin Ludwig and four scientific sessions on the molecular regulation of craniofacial development, craniofacial morphogenesis, translational craniofacial biology, and signaling during craniofacial development. The meeting also included workshops on career development, NIH/NIDCR funding, and the utility of the FaceBase database, as well as two poster sessions. Over 190 attendees from 21 states, representing over 50 different scientific institutions, participated. This diverse group of scientists included cell biologists, developmental biologists, and clinical geneticists. While in-person interactions were missed due to the virtual meeting format imposed by the COVID-19 pandemic, the meeting platform provided ample opportunities for participant interactions and discussions, thus strengthening the community.
Subject(s)
Craniofacial Abnormalities/genetics , Developmental Biology , Animals , COVID-19 , Congresses as Topic/organization & administration , Craniofacial Abnormalities/embryology , Genetics, Medical , Humans , Pandemics , Societies, Medical/organization & administration , Societies, Scientific/organization & administration , VideoconferencingABSTRACT
We calculated carbon emissions associated with air travel of 4,834 participants at the 2019 annual conference of the American Society of Tropical Medicine and Hygiene (ASTMH). Together, participants traveled a total of 27.7 million miles or 44.6 million kilometers. This equates to 58 return trips to the moon. Estimated carbon dioxide equivalent (CO2e) emissions were 8,646 metric tons or the total weekly carbon footprint of approximately 9,366 average American households. These emissions contribute to climate change and thus may exacerbate many of the global diseases that conference attendees seek to combat. Options to reduce conference travel-associated emissions include 1) alternating in-person and online conferences, 2) offering a hybrid in-person/online conference, and 3) decentralizing the conference with multiple conference venues. Decentralized ASTMH conferences may allow for up to 64% reduction in travel distance and 58% reduction in CO2e emissions. Given the urgency of the climate crisis and the clear association between global warming and global health, ways to reduce carbon emissions should be considered.
Subject(s)
Carbon Footprint , Hygiene , Societies, Scientific/organization & administration , Travel , Tropical Medicine , Climate Change , Humans , United StatesABSTRACT
Due to the COVID-19 pandemic, the 84thAnnual Meeting of the Japanese Circulation Society (JCS) was held in a web-based format for the first time in its history as "The Week for JCS 2020" from Monday, July 27 to Sunday, August 2, 2020. All sessions, including general abstracts, were streamed live or on-demand. The main theme of the meeting was "Change Practice!" and the aim was to organize the latest findings in the field of cardiovascular medicine and discuss how to change practice. The total number of registered attendees was over 16,800, far exceeding our expectations, and many of the sessions were viewed by far more people than at conventional face-to-face scientific meetings. At this conference, the power of online information dissemination was fully demonstrated, and the evolution of online academic meetings will be a direction that cannot be reversed in the future. The meeting was completed with great success, and we express our heartfelt gratitude to all affiliates for their enormous amount of work, cooperation, and support.
Subject(s)
Cardiology/organization & administration , Congresses as Topic/organization & administration , Societies, Scientific/organization & administration , Telecommunications/organization & administration , Cardiology/trends , Cardiovascular Diseases/diagnostic imaging , Cardiovascular Diseases/therapy , Congresses as Topic/statistics & numerical data , Congresses as Topic/trends , Humans , Japan , Research , Surveys and Questionnaires , Telecommunications/statistics & numerical data , Telecommunications/trendsSubject(s)
COVID-19 Vaccines/administration & dosage , COVID-19/prevention & control , Information Dissemination/methods , Mass Vaccination/organization & administration , Social Media , COVID-19/epidemiology , COVID-19/immunology , COVID-19/virology , Cultural Competency , Ethnicity/psychology , Humans , Intersectoral Collaboration , Mass Vaccination/psychology , Minority Groups/psychology , Patient Acceptance of Health Care/psychology , SARS-CoV-2/immunology , Societies, Medical/organization & administration , Societies, Scientific/organization & administration , Socioeconomic Factors , Trust , United Kingdom/epidemiologyABSTRACT
The year 2020 is an extremely unusual year. The world lost more than one million lives due to the attack of COVID-19. Economic production has been greatly reduced, and daily activities are largely restricted. Luckily the work of Chinese Journal of Traumatology (CJTEE) has not been adversely affected. 2020 is a harvest year for the journal, which (1) was included in the high-quality academic journals by China Association for Science and Technology; (2) cover of each issue is newly designed; (3) submission increased by about 60% with more countries and regions covered; (4) usage in the ScienceDirect database exceeded a million; (5) the CiteScore rises to more than 2.0 the first time. This study reviewed the articles published in the year 2020 by CJTEE.
Subject(s)
COVID-19 , Periodicals as Topic , Science/organization & administration , Societies, Scientific/organization & administration , Technology/organization & administration , Traumatology/organization & administration , Wounds and Injuries , China , Humans , Time Factors , Wounds and Injuries/etiologySubject(s)
Congresses as Topic , Nuclear Medicine/organization & administration , Nuclear Medicine/trends , Societies, Scientific/organization & administration , COVID-19 , Computer Communication Networks , Coronavirus Infections/prevention & control , Japan , Pandemics/prevention & control , Pneumonia, Viral/prevention & controlSubject(s)
Congresses as Topic , Nuclear Medicine/organization & administration , Nuclear Medicine/trends , Societies, Scientific/organization & administration , COVID-19 , Computer Communication Networks , Coronavirus Infections/prevention & control , Japan , Pandemics/prevention & control , Pneumonia, Viral/prevention & controlSubject(s)
Congresses as Topic , Nuclear Medicine/organization & administration , Nuclear Medicine/trends , Societies, Scientific/organization & administration , COVID-19 , Computer Communication Networks , Coronavirus Infections/prevention & control , Japan , Pandemics/prevention & control , Pneumonia, Viral/prevention & controlABSTRACT
The COVID-19 pandemic is shining a spotlight on the field of immunology like never before. To appreciate the diverse ways in which immunologists have contributed, Nature Reviews Immunology invited the president of the International Union of Immunological Societies and the presidents of 15 other national immunology societies to discuss how they and their members responded following the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Subject(s)
COVID-19/epidemiology , Coronavirus Infections/epidemiology , International Cooperation , Pandemics , Pneumonia, Viral/epidemiology , Severe Acute Respiratory Syndrome/epidemiology , Societies, Scientific/organization & administration , Antiviral Agents/chemical synthesis , Antiviral Agents/therapeutic use , Betacoronavirus/drug effects , Betacoronavirus/immunology , Betacoronavirus/pathogenicity , COVID-19/immunology , COVID-19/prevention & control , COVID-19/therapy , COVID-19 Vaccines , Community-Institutional Relations , Coronavirus Infections/immunology , Coronavirus Infections/prevention & control , Coronavirus Infections/therapy , Global Health/trends , Humans , Patient Education as Topic/organization & administration , Personal Protective Equipment/supply & distribution , Pneumonia, Viral/immunology , Pneumonia, Viral/therapy , SARS-CoV-2 , Severe Acute Respiratory Syndrome/immunology , Severe Acute Respiratory Syndrome/therapy , Viral Vaccines/biosynthesisSubject(s)
Betacoronavirus/isolation & purification , Coronavirus Infections/complications , Pneumonia, Viral/complications , Societies, Scientific/organization & administration , Thrombosis/etiology , COVID-19 , Coronavirus Infections/epidemiology , Coronavirus Infections/pathology , Coronavirus Infections/virology , Hemostasis/physiology , History, 21st Century , Humans , Male , Pandemics , Periodicals as Topic , Pneumonia, Viral/epidemiology , Pneumonia, Viral/pathology , Pneumonia, Viral/virology , SARS-CoV-2 , Thrombosis/physiopathologyABSTRACT
The recent resignation of the President of the European Research Council (ERC) Mauro Ferrari has opened a wide discussion both on the method of designation of the President of the ERC and on the validity of the different funding mechanisms for scientific research. From this point of view, Sars-CoV-2 was not only responsible for the pandemic, but also triggered a debate on an alleged primacy of applied research over the fundamental research.
Subject(s)
Societies, Scientific/organization & administration , Europe , Research/economics , Societies, Scientific/economicsABSTRACT
The SARS-CoV-2 virus is responsible for an epidemic disease called COVID-19, which was initially evidenced in Wuhan, China, and spread very rapidly in China and around the world. In France, the first isolated case seems now to be reported in December 2019, stage 3 of the COVID-19 epidemic was triggered on March 14th, the start of the planned containment exit from May 11th. Healthcare services have faced a large influx of patients who may be beyond their capacity to receive and care, particularly in the Large-East and Ile-de-France regions. Some patients show an evolution of the disease never observed before with other coronaviruses and develop in a few days a very important inflammatory reaction, which can lead to death of patients. A working group of the French Society of Clinical Biology (SFBC) was set up with the objective of providing updated information on the current status of the biological prescriptions (focusing on biochemistry ones) and their evolution during the epidemic, and of analyzing the biological parameters associated with comorbidities and patient evolution in order to link biological results with medical events. The expanded working group covers all sectors of medical biology in France and extends to the French-speaking world: hospital sectors (CHU and CH, Army Training Hospitals) and the private sector opening a field of view on the biological situation in establishments for dependent elderly, social establishments and clinical medical institutions. The purpose of this article is the presentation of this working group and its immediate and future actions.